Share

February 2022; 12 (1) Research

COVID-19 Outcomes in Hospitalized Patients With Neurodegenerative Disease

A Retrospective Cohort Study

Roshni Abee Patel, Glenn T. Stebbins, Ekta B. Kishen, Brandon Barton
First published July 16, 2021, DOI: https://doi.org/10.1212/CPJ.0000000000001117
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
554

Share

Article Information

vol. 12 no. 1 43-51
DOI: 
https://doi.org/10.1212/CPJ.0000000000001117
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received December 31, 2020
  • Accepted June 30, 2021
  • First Published July 16, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Roshni Abee Patel, MD,
    2. Glenn T. Stebbins, PhD (glenn_stebbins{at}rush.edu),
    3. Ekta B. Kishen, MPH (ekta_b_kishen{at}rush.edu) and
    4. Brandon Barton, MD, MS (brandon_r_barton{at}rush.edu)
  1. Roshni Abee Patel, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Glenn T. Stebbins, PhD (glenn_stebbins{at}rush.edu),
    3. Scientific Advisory Boards:

    1. 1. Ultragenyx Pharmaceutical 2. Medgenesis 3. Cleveland Clinic Foundation

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1. International Parkinson and Movement Disorder Society - Travel 2. Dystonia Coalition - Travel 3. American Academy of Neurology - Honoraria 4. Michael J. Fox Foundation for Parkinson's Research - Honoraria 5. Food and Drug Administration - Honoraria 6. National Institutes of Health - Honoraria 7. TOXINS - Travel 8. American Society for Experimental Neurotherapeutics - Travel

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Acadia Pharmaceuticals 2. Adamas Pharmaceuticals, Inc. 3. Ceregene, Inc. 4. CHDI Management, Inc. 5. Ingenix Pharmaceutical Services (i3 Research) 6. Neurocrine Biosciences, Inc. 7. Pfizer, Inc. 8. Tool-4-Patient

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. US Army Medical Research and Materiel Command, PR161108, Co-I, 2017- 2022

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1. Michael J. Fox Foundation for Parkinson's Research 2. CHDI 3. Dystonia Coalition 4. International Parkinson and Movement Disorder Society 5. CBD Solution

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Ekta B. Kishen, MPH (ekta_b_kishen{at}rush.edu) and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Brandon Barton, MD, MS (brandon_r_barton{at}rush.edu)
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. honoraria from pharmaceutical companies for consultancy

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurological Sciences (RAP, GTS, BB), Rush University Medical Center, Chicago, IL; Bioinformatics and Biostatistics Core (EBK), Rush University Medical Center, Chicago, IL; and Neurology Service (BB), Jesse Brown Veterans Affairs Medical Center, Chicago, IL.
  1. Correspondence
    Dr. Patel roshnipatel1988{at}gmail.com
View Full Text

Article usage

Article usage: July 2021 to January 2023

AbstractFullPdfSource
Jul 2021655039Highwire
Aug 2021527059Highwire
Sep 2021159020Highwire
Oct 2021271025Highwire
Nov 202197021Highwire
Dec 2021105021Highwire
Jan 20228108Highwire
Feb 202222260484Highwire
Mar 202220042777Highwire
Apr 202211617031Highwire
May 2022126616Highwire
Jun 202294822Highwire
Jul 202211728Highwire
Aug 202254916Highwire
Sep 202269032Highwire
Oct 202267324Highwire
Nov 2022128320Highwire
Dec 202244412Highwire
Jan 202365319Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me